To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1467335 Following Multiple Dose Administration Over 28 Days
Clinical trial NCT02733627 · COMPLETED
Trial details
- NCT number
- NCT02733627
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-07
- Primary completion
- 2017-07-12
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.